
In a world filled with pharmaceutical advancements and medical breakthroughs, a recent federal study has shed light on the possible benefits of two popular drugs, Ozempic and Wegovy. These drugs, primarily prescribed for diabetes and obesity management, have been found to be associated with a lower risk of suicidal thoughts compared to other medications used for the same conditions. Talk about an unexpected twist!
Funded by the National Institutes of Health and conducted by researchers from Case Western Reserve University, the study analyzed the electronic medical records of over 1.8 million patients who were prescribed semaglutide or another drug for diabetes or obesity between the years 2017 and 2022. The results were nothing short of surprising. It turns out that patients taking semaglutide had a significantly reduced risk, ranging from 49% to 73%, of experiencing suicidal thoughts compared to those on alternative medications during the follow-up period of six months.